G01N 33/6857
Antibody fragments
Official title: {Antibody fragments}
G01N33/6857 (Antibody fragments) appears on 358 US grants and 555 published applications in this corpus.
Search patents in G01N- Granted patents
- 358
- Published applications
- 555
- Assignees
- 314
- Inventors
- 1,282
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 4 | 0 |
| 1990 | 9 | 0 |
| 1991 | 5 | 0 |
| 1992 | 4 | 0 |
| 1993 | 5 | 0 |
| 1994 | 3 | 0 |
| 1995 | 5 | 0 |
| 1996 | 1 | 0 |
| 1997 | 9 | 0 |
| 1998 | 4 | 0 |
| 1999 | 10 | 0 |
| 2000 | 2 | 0 |
| 2001 | 9 | 0 |
| 2002 | 2 | 9 |
| 2003 | 0 | 13 |
| 2004 | 6 | 10 |
| 2005 | 5 | 13 |
| 2006 | 6 | 10 |
| 2007 | 5 | 16 |
| 2008 | 5 | 11 |
| 2009 | 7 | 11 |
| 2010 | 14 | 20 |
| 2011 | 3 | 13 |
| 2012 | 10 | 16 |
| 2013 | 6 | 21 |
| 2014 | 12 | 22 |
| 2015 | 10 | 16 |
| 2016 | 16 | 19 |
| 2017 | 6 | 23 |
| 2018 | 11 | 27 |
| 2019 | 16 | 52 |
| 2020 | 21 | 35 |
| 2021 | 15 | 37 |
| 2022 | 24 | 30 |
| 2023 | 22 | 39 |
| 2024 | 17 | 40 |
| 2025 | 23 | 34 |
| 2026 | 15 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Treatment of autoimmune liver disease15 Sep 2026US 12,736,544 B2The Governors of the University of Alberta
- Xseq8 Sep 2026US 12,729,460 B1Verily Health Inc.
- Multiplexed total antibody and antibody-conjugated drug quantification assay21 Jul 2026US 12,687,549 B2Genentech, Inc.
- Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains23 Jun 2026US 12,662,525 B2Ablynx N. V.
- Binding molecule binding to traumatic brain injury-associated tau and methods of use thereof23 Jun 2026US 12,662,678 B2Arizona Board of Regents on behalf of Arizona State University
- Methods of determining relative unpaired glycan content1 Oct 2026US 2026/0298943 A1Amgen Inc.
- Chimeric receptor for use in whole-cell sensors for detecting analytes of interest27 Aug 2026US 2026/0251653 A1Centre National de la Recherche Scientifique (CNRS)
- Methods of selecting antibodies and antibody fragments13 Aug 2026US 2026/0234720 A1Allele Biotechnology & Pharmaceuticals, Inc.
- System and method for analyzing antibody co-formulations6 Aug 2026US 2026/0227390 A1Amgen Inc.
- Extracellular Matrix Binding Compounds for the Localized Loading of Therapeutic or Diagnostic Agents23 Jul 2026US 2026/0209291 A1Kamino ApS
Most cited
By later US patents
- Methods for producing members of specific binding pairs893US 5,969,108 ACambridge Antibody Technology Limited · 1999
- Methods for producing members of specific binding pairs240US 5,871,907 ACambridge Antibody Technology Limited · 1999
- Bispecific antibodies for selective immune regulation and for selective immune cell binding233US 5,601,819 AThe General Hospital Corporation · 1997
- Identification and engineering of antibodies with variant Fc regions and methods of using same227US 7,355,008 B2MacroGenics, Inc. · 2008
- Preparation and use of immunoconjugates182US 5,443,953 AImmunomedics, Inc. · 1995